Association of high sensitivity C-reactive protein and abdominal aortic aneurysm: a meta-analysis and systematic review

References

• Jones GT, Phillips LV, Williams MJ, et al. Two C-C family chemokines, eotaxin and RANTES, are novel independent plasma biomarkers for abdominal aortic aneurysm. J Am Heart Assoc 2016;5: pii: e002993
   PubMed Web of Science ®Google Scholar
• Stather PW, Sidloff DA, Rhema IA, et al. A review of current reporting of abdominal aortic aneurysm mortality and prevalence in the literature. Eur J Vasc Endovasc Surg 2014;47:240-2
   PubMed Web of Science ®Google Scholar
• LeFevre ML. Screening for abdominal aortic aneurysm: US Preventive Services Task Force recommendation statement. Ann Intern Med 2014;161:281-90
   PubMed Web of Science ®Google Scholar
• De Haro J, Acin F, Bleda S, et al. Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels. J Vasc Surg 2012;56:45-52
   PubMed Web of Science ®Google Scholar
• De Haro J, Bleda S, Acin F. C-reactive protein predicts aortic aneurysmal disease progression after endovascular repair. Int J Cardiol 2016;202:701-6
   PubMed Web of Science ®Google Scholar
• Takagi H, Manabe H, Kawai N, et al. Regarding “C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm”. J Vasc Surg 2009;50:240; author reply 240-1
   PubMed Web of Science ®Google Scholar
• Darwood RJ, Brooks MJ. The impact of decreasing abdominal aortic aneurysm prevalence on a local aneurysm screening programme. Eur J Vasc Endovasc Surg 2012;44:45-50
   PubMed Web of Science ®Google Scholar
• Gianfagna F, Veronesi G, Bertù L, et al. Prevalence of abdominal aortic aneurysms and its relation with cardiovascular risk stratification: protocol of the Risk of Cardiovascular diseases and abdominal aortic Aneurysm in Varese (RoCAV) population based study. BMC Cardiovasc Disord 2016;16:243
   PubMed Web of Science ®Google Scholar
• Benson RA, Poole R, Murray S, et al. Screening results from a large United Kingdom abdominal aortic aneurysm screening center in the context of optimizing United Kingdom National Abdominal Aortic Aneurysm Screening Programme protocols. J Vasc Surg 2016;63:301-4
   PubMed Web of Science ®Google Scholar
• Ulug P, Sweeting MJ, von Allmen RS, et al. Morphological suitability for endovascular repair, non-intervention rates, and operative mortality in women and men assessed for intact abdominal aortic aneurysm repair: systematic reviews with meta-analysis. Lancet 2017;389:2482-91
   PubMed Web of Science ®Google Scholar
• Gwon JG, Kwon TW, Cho YP, et al. Analysis of in hospital mortality and long-term survival excluding in hospital mortality after open surgical repair of ruptured abdominal aortic aneurysm. Ann Surg Treat Res 2016;91:303-8
   PubMed Web of Science ®Google Scholar
• Stather PW, Sidloff DA, Dattani N, et al. Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm. Br J Surg 2014;101:1358-72
   PubMed Web of Science ®Google Scholar
• Stather PW, Dattani N, Bown MJ, et al. International variations in AAA screening. Eur J Vasc Endovasc Surg 2013;45:231-4
   PubMed Web of Science ®Google Scholar
• Sidloff DA, Stather PW, Choke E, et al. A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size. J Vasc Surg 2014;59:528-35 e524
   PubMed Web of Science ®Google Scholar
• Wilson PW, Pencina M, Jacques P, et al. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008;1:92-7
   PubMed Web of Science ®Google Scholar
• Cagli K, Tok D, Turak O, et al. Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size. Biomark Med 2016;10:1039-47
   PubMed Web of Science ®Google Scholar
• Piechota-Polanczyk A, Jozkowicz A, Nowak W, et al. The abdominal aortic aneurysm and intraluminal thrombus: current concepts of development and treatment. Front Cardiovasc Med 2015;2:19
   PubMedGoogle Scholar
• Vainas T, Lubbers T, Stassen FR, et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 2003;107:1103-5
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Available at: http://www.medicine.mcgill.ca/rtamblyn/Readings/The%20Newcastle%20-%20Scale%20for%20assessing%20the%20quality%20of%20. (Access date: Nov 2, 2016)
   Google Scholar
• DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 2007;28:105-14
   PubMed Web of Science ®Google Scholar
• Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008;37:1148-57
   PubMed Web of Science ®Google Scholar
• Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002
   PubMed Web of Science ®Google Scholar
• Sohrabi S, Wheatcroft S, Barth JH, et al. Cardiovascular risk in patients with small and medium abdominal aortic aneurysms, and no history of cardiovascular disease. Br J Surg 2014;101:1238-43
   PubMed Web of Science ®Google Scholar
• Qin Y, Yang Y, Liu R, et al. Combined cathepsin S and hs-CRP predicting inflammation of abdominal aortic aneurysm. Clin Biochem 2013;46:1026-9
   PubMed Web of Science ®Google Scholar
• Villard C, Wagsater D, Swedenborg J, et al. Biomarkers for abdominal aortic aneurysms from a sex perspective. Gend Med 2012;9:259-66 e252
   PubMedGoogle Scholar
• Parry DJ, Al-Barjas HS, Chappell L, et al. Markers of inflammation in men with small abdominal aortic aneurysm. J Vasc Surg 2010;52:145-51
   PubMed Web of Science ®Google Scholar
• Vega de Céniga M, Esteban M, Quintana JM, et al. Search for serum biomarkers associated with abdominal aortic aneurysm growth – a pilot study. Eur J Vasc Endovasc Surg 2009;37:297-9
   PubMed Web of Science ®Google Scholar
• Palazzuoli A, Gallotta M, Guerrieri G, et al. Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag 2008;4:877-83
   PubMedGoogle Scholar
• Wanhainen A, Bergqvist D, Boman K, et al. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg 2005;41:390-6
   PubMed Web of Science ®Google Scholar
• Hellenthal FA, Pulinx B, Welten RJ, et al. Circulating biomarkers and abdominal aortic aneurysm size. J Surg Res 2012;176:672-8
   PubMed Web of Science ®Google Scholar
• Golledge J, Muller J, Shephard N, et al. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2007;27:655-60
   PubMed Web of Science ®Google Scholar
• Wong YY, Flicker L, Yeap BB, et al. Is hypovitaminosis D associated with abdominal aortic aneurysm, and is there a dose–response relationship? Eur J Vasc Endovasc Surg 2013;45:657-64
   PubMed Web of Science ®Google Scholar
• Golledge J, Clancy P, Yeap BB, et al. Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. Int J Cardiol 2013;167:1159-63
   PubMed Web of Science ®Google Scholar
• Liao M, Liu CL, Lv BJ, et al. Plasma cytokine levels and risks of abdominal aortic aneurysms: a population-based prospective cohort study. Ann Med 2015;47:245-52
   PubMed Web of Science ®Google Scholar
• Schweitzer M, Mitmaker B, Obrand D, et al. Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms. Vasc Endovascular Surg 2010;44:116-22
   PubMed Web of Science ®Google Scholar
• Wilson WR, Evans J, Bell PR, et al. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2005;30:259-62
   PubMed Web of Science ®Google Scholar
• Domanovits H, Schillinger M, Mullner M, et al. Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis 2002;163:297-302
   PubMed Web of Science ®Google Scholar
• Norman P, Spencer CA, Lawrence-Brown MM, et al. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 2004;110:862-6
   PubMed Web of Science ®Google Scholar
• Lindholt JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg 2001;88:1472
   PubMed Web of Science ®Google Scholar
• Wołoszko T, Skórski M, Kwasiborski P, et al. Influence of selective biochemical and morphological agents on natural history of aneurysm of abdominal aorta development. Med Sci Monit 2016;22:431-7
   PubMed Web of Science ®Google Scholar
• Folsom AR, Yao L, Alonso A, et al. Circulating biomarkers and abdominal aortic aneurysm incidence: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2015;132:578-85
   PubMed Web of Science ®Google Scholar